Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management

References

• Abbas H, El-Deeb NM, Zewail M. (2021). PLA-coated Imwitor® 900 K-based herbal colloidal carriers as novel candidates for the intra-articular treatment of arthritis. Pharmaceutical Development and Technology 26:1663–11.
   Web of Science ®Google Scholar
• Abd El Azim H, Nafee N, Ramadan A, Khalafallah N. (2015). Liposomal buccal mucoadhesive film for improved delivery and permeation of water-soluble vitamins. Int J Pharm 488:78–85.
   PubMed Web of Science ®Google Scholar
• Acevedo-Morantes CY, Acevedo-Morantes MT, Suleiman-Rosado D, Ramírez-Vick JE. (2013). Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells. Drug Deliv 20:338–48.
   PubMed Web of Science ®Google Scholar
• Ahmad A, Mondal SK, Mukhopadhyay D, et al. (2016). Development of liposomal formulation for delivering anticancer drug to breast cancer stem-cell-like cells and its pharmacokinetics in an animal model. Mol Pharm 13:1081–8.
   PubMed Web of Science ®Google Scholar
• Ahmed S, Kassem MA, Sayed S. (2020). Bilosomes as promising nanovesicular carriers for improved transdermal delivery: construction, in vitro optimization, ex vivo permeation and in vivo evaluation. Int J Nanomedicine 15:9783–98.
   PubMed Web of Science ®Google Scholar
• Badie H, Abbas H. (2018). Novel small self-assembled resveratrol-bearing cubosomes and hexosomes: preparation, charachterization, and ex vivo permeation. Drug Dev Ind Pharm 44:2013–25.
   PubMed Web of Science ®Google Scholar
• Bae J, Park JW. (2016). Topical delivery of leflunomide for rheumatoid arthritis treatment: evaluation of local tissue deposition of teriflunomide and its anti-inflammatory effects in an arthritis rat model. Drug Dev Ind Pharm 42:254–62.
   PubMed Web of Science ®Google Scholar
• Bahr HI, Toraih EA, Mohammed EA, et al. (2015). Chemopreventive effect of leflunomide against Ehrlich’s solid tumor grown in mice: effect on EGF and EGFR expression and tumor proliferation. Life Sci 141:193–201.
   PubMed Web of Science ®Google Scholar
• Can AS, Erdal MS, Güngör S, Özsoy Y. (2013). Optimization and characterization of chitosan films for transdermal delivery of ondansetron. Molecules 18:5455–71.
   PubMed Web of Science ®Google Scholar
• Chantasart D, Li SK, He N, et al. (2004). Mechanistic studies of branched-chain alkanols as skin permeation enhancers. J Pharm Sci 93:762–79.
   PubMed Web of Science ®Google Scholar
• Chittasupho C, Anuchapreeda S, Sarisuta N. (2017). CXCR4 targeted dendrimer for anti-cancer drug delivery and breast cancer cell migration inhibition. Eur J Pharm Biopharm 119:310–21.
   PubMed Web of Science ®Google Scholar
• Costa B, Amorim I, Gärtner F, Vale N. (2020). Understanding breast cancer: from conventional therapies to repurposed drugs. Eur J Pharm Sci 151:105401.
   PubMed Web of Science ®Google Scholar
• Dian L, Yang Z, Li F, et al. (2013). Cubic phase nanoparticles for sustained release of ibuprofen: formulation, characterization, and enhanced bioavailability study. Int J Nanomed 8:845.
   PubMed Web of Science ®Google Scholar
• El-Enin HA, Al-Shanbari AH. (2018). Nanostructured liquid crystalline formulation as a remarkable new drug delivery system of anti-epileptic drugs for treating children patients. Saudi Pharm J 26:790–800.
   PubMed Web of Science ®Google Scholar
• El-Sayyad NME-M, Badawi A, Abdullah ME, Abdelmalak NS. (2017). Dissolution enhancement of leflunomide incorporating self emulsifying drug delivery systems and liquisolid concepts. Bull Fac Pharm 55:53–62.
   Google Scholar
• El-Setouhy DA, Abdelmalak NS, Anis SE, Louis D. (2015). Leflunomide biodegradable microspheres intended for intra-articular administration: development, anti-inflammatory activity and histopathological studies. Int J Pharm 495:664–70.
   PubMed Web of Science ®Google Scholar
• Elgindy NA, Mehanna MM, Mohyeldin SM. (2016). Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery. Int J Pharm 501:167–79.
   PubMed Web of Science ®Google Scholar
• El-Masry SR, Hathout RM, Abdel-Halim M, Mansour S. (2018). In vitro transdermal delivery of sesamol using oleic acid chemically-modified gelatin nanoparticles as a potential breast cancer medication. J Drug Delivery Sci Technol 48:30–9.
   Web of Science ®Google Scholar
• Elmowafy M, Al-Sanea MM. (2021). Nanostructured lipid carriers (NLCs) as drug delivery platform: advances in formulation and delivery strategies. Saudi Pharm J 29:999–1012.
   PubMed Web of Science ®Google Scholar
• Esposito E, Cortesi R, Drechsler M, et al. (2005). Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res 22:2163–73.
   PubMed Web of Science ®Google Scholar
• Fontana G, Maniscalco L, Schillaci D, et al. (2005). Solid lipid nanoparticles containing tamoxifen characterization and in vitro antitumoral activity. Drug Deliv 12:385–92.
   PubMed Web of Science ®Google Scholar
• Gaballa SA, El Garhy OH, Abdelkader H. (2020). Cubosomes: composition, preparation, and drug delivery applications. J Adv Biomed Pharma Sci 3:1–9.
   Google Scholar
• Guo C, Wang J, Cao F, et al. (2010). Lyotropic liquid crystal systems in drug delivery. Drug Discov Today 15:1032–40.
   PubMed Web of Science ®Google Scholar
• Guo X, Zhao Z, Chen D, et al. (2019). Co-delivery of resveratrol and docetaxel via polymeric micelles to improve the treatment of drug-resistant tumors. Asian J Pharm Sci 14:78–85.
   PubMed Web of Science ®Google Scholar
• Gupta U, Dwivedi SKD, Bid HK, et al. (2010). Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells. Int J Pharm 393:186–97.
   Web of Science ®Google Scholar
• Hashem F, Nasr M, Youssif M. J J o A P R. (2018). Formulation and characterization of cubosomes containing REB for improvement of oral absorption of the drug in human volunteers. J Adv Pharm Res 2:95–103.
   Google Scholar
• Huang O, Zhang W, Zhi Q, et al. (2015). Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells. Exp Biol Med 240:426–37.
   PubMed Web of Science ®Google Scholar
• Keen I, Conaghan HPG, Tett SE. (2013).Safety evaluation of leflunomide in rheumatoid arthritis. Expert Opin Drug Saf 12:581–8.
   PubMed Web of Science ®Google Scholar
• Iacoviello L, Bonaccio M, de Gaetano G, Donati MB. (2021). Epidemiology of breast cancer, a paradigm of the “common soil” hypothesis. Semin Cancer Biol 72:4–10.
   PubMed Web of Science ®Google Scholar
• Jain AK, Thanki K, Jain S. (2013). Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity. Mol Pharm 10:3459–74.
   PubMed Web of Science ®Google Scholar
• Jain V, Kumar H, Anod HV, et al. (2020). A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer. J Control Release 326:628–47.
   PubMed Web of Science ®Google Scholar
• Jenni S, Picci G, Fornasier M, et al. (2020). Multifunctional cubic liquid crystalline nanoparticles for chemo- and photodynamic synergistic cancer therapy. Photochem Photobiol Sci 19:674–80.
   PubMed Web of Science ®Google Scholar
• Lai J, Chen J, Lu Y, et al. (2009). Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. in vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin. Aaps Pharmscitech 10:960–6.
   PubMed Web of Science ®Google Scholar
• Li S-Y, Sun R, Wang H-X, et al. (2015). Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells. J Control Release 205:7–14.
   PubMed Web of Science ®Google Scholar
• Luo Q, Lin T, Zhang CY, et al. (2015). A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: preparation, cytotoxicity and intracellular uptake. Int J Pharm 493:30–9.
   PubMed Web of Science ®Google Scholar
• Mehanna MM, Sarieddine R, Alwattar JK, et al. (2020). Anticancer activity of thymoquinone cubic phase nanoparticles against human breast cancer: formulation, cytotoxicity and subcellular localization. Int J Nanomedicine 15:9557–70.
   PubMed Web of Science ®Google Scholar
• Mohyeldin S, Mehanna M, Elgindy N. (2016). Superiority of liquid crystalline cubic nanocarriers as hormonal transdermal vehicle: comparative human skin permeation-supported evidence. Expert Opin Drug Deliv 13:1049–64.
   PubMed Web of Science ®Google Scholar
• Nasr M, Almawash S, Al Saqr A, et al. (2021). Bioavailability and antidiabetic activity of gliclazide-loaded cubosomal nanoparticles. Pharmaceuticals 14:786.
   Web of Science ®Google Scholar
• Nasr M, Younes H, Abdel-Rashid RS. (2020). Formulation and evaluation of cubosomes containing colchicine for transdermal delivery. Drug Deliv Transl Res 10:1302–13.
   PubMed Web of Science ®Google Scholar
• Nazaruk E, Majkowska‐Pilip A, Bilewicz R. (2017). Lipidic cubic-phase nanoparticles-cubosomes for efficient drug delivery to cancer cells. ChemPlusChem 82:570–5.
   PubMed Web of Science ®Google Scholar
• O’Donnell EF, Saili KS, Koch DC, et al. (2010). The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor. PLoS One 5:e13128.
   PubMed Web of Science ®Google Scholar
• Omar S, Ismail A, Hassanin K, Hamdy S. (2019). Formulation and evaluation of cubosomes as skin retentive system for topical delivery of clotrimazole. J Adv Pharm Res 3:68–82.
   Google Scholar
• Pal K, Roy S, Parida PK, et al. (2019). Folic acid conjugated curcumin loaded biopolymeric gum acacia microsphere for triple negative breast cancer therapy in invitro and invivo model. Mater Sci Eng C Mater Biol Appl 95:204–16.
   PubMed Web of Science ®Google Scholar
• Peng X, Zhou Y, Han K, et al. (2015). Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin. Drug Des Devel Ther 9:4209–18.
   PubMed Web of Science ®Google Scholar
• Pytel D, Sliwinski T, Poplawski T, et al. (2009). Tyrosine kinase blockers: new hope for successful cancer therapy.Anticancer Agents Med Chem 9:66–76.
   PubMed Web of Science ®Google Scholar
• Rahman HS, Rasedee A, How CW, et al. (2013). Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomedicine 8:2769–81.
   PubMed Web of Science ®Google Scholar
• Ribeiro A, Sosnik A, Chiappetta DA, et al. (2012). Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy. J R Soc Interface 9:2059–69.
   PubMed Web of Science ®Google Scholar
• Salah S, Mahmoud AA, Kamel AO. (2017). Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies. Drug Deliv 24:846–56.
   PubMed Web of Science ®Google Scholar
• Salentinig S, Sagalowicz L, Glatter OJL. (2010). Self-assembled structures and pKa value of oleic acid in systems of biological relevance. Langmuir 26:11670–9.
   PubMed Web of Science ®Google Scholar
• Sanders S, Harisdangkul V. (2002). Leflunomide for the treatment of rheumatoid arthritis and autoimmunity. Am J Med Sci 323:190–3.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal AJC. (2019). Cancer statistics 2019. CA Cancer J Clin 69:7–34.
   PubMed Web of Science ®Google Scholar
• Srisongkram T, Weerapreeyakul N. (2019).Validation of cell-based assay for quantification of sesamol uptake and its application for measuring target exposure. Molecules 24:3522.
   PubMed Web of Science ®Google Scholar
• Sun M, Nie S, Pan X, et al. (2014). Quercetin-nanostructured lipid carriers: characteristics and anti-breast cancer activities in vitro. Colloids Surf B Biointerfaces 113:15–24.
   PubMed Web of Science ®Google Scholar
• Tong CW, Wu M, Cho W, To KKJ. (2018). Recent advances in the treatment of breast cancer. Front Oncol. 8:227.
   PubMed Web of Science ®Google Scholar
• Vieira DB, Gamarra LF. (2016). Advances in the use of nanocarriers for cancer diagnosis and treatment. Einstein 14:99–103.
   PubMed Web of Science ®Google Scholar
• White RM, Cech J, Ratanasirintrawoot S, et al. (2011). DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 471:518–22.
   PubMed Web of Science ®Google Scholar
• Zewail M. (2021). Folic acid decorated chitosan-coated solid lipid nanoparticles for the oral treatment of rheumatoid arthritis. Therapeutic Delivery 12:297–310.
   PubMed Web of Science ®Google Scholar
• Zewail M, Nafee N, Helmy MW, Boraie N. (2019). Coated nanostructured lipid carriers targeting the joints – an effective and safe approach for the oral management of rheumatoid arthritis. Int J Pharm 567:118447.
   PubMed Web of Science ®Google Scholar
• Zhang C, Chu M. (2018). Leflunomide: a promising drug with good antitumor potential. Biochem Biophys Res Commun 496:726–30.
   PubMed Web of Science ®Google Scholar